MRD検査市場レポート：2030年までの動向、予測、競合分析

MRD検査の動向と予測

世界のMRD検査市場は、2024年から2030年までのCAGRが12.8%で、2030年までに推定44億米ドルに達すると予想されます。この市場の主な促進要因は、血液関連がんの増加、世界の高齢者人口の増加、微小残存病変（MRD）検査技術の進歩です。世界のMRD検査市場の将来は、病院や専門クリニック、診断研究所、学術・研究機関市場におけるビジネスチャンスで有望視されています。

MRD検査市場の洞察

Lucintelは、ポリメラーゼ連鎖反応（PCR）が予測期間中に最も高い成長を遂げると予測しています。

この市場の中では、病院と専門クリニックが最大のセグメントであり続けるでしょう。

アジア太平洋は予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答しています：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のMRD検査市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のMRD検査市場動向（2018～2023年）と予測（2024～2030年）
• 技術別の世界のMRD検査市場
  • フローサイトメトリー
  • ポリメラーゼ連鎖反応（PCR）
  • 次世代シーケンス（NGS）
  • その他
• アプリケーション別の世界のMRD検査市場
  • 血液悪性腫瘍
  • 白血病
  • リンパ腫
  • 固形腫瘍
  • その他
• 最終用途産業別の世界のMRD検査市場
  • 病院と専門クリニック
  • 診断研究所
  • 学術調査機関
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界のMRD検査市場
• 北米のMRD検査市場
• 欧州のMRD検査市場
• アジア太平洋 MRD検査市場
• その他地域 MRD検査市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 技術別の世界のMRD検査市場の成長機会
  • アプリケーション別の世界のMRD検査市場の成長機会
  • 最終用途産業別の世界のMRD検査市場の成長機会
  • 地域別の世界のMRD検査市場の成長機会
• 世界のMRD検査市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のMRD検査市場の能力拡大
  • 世界のMRD検査市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Labcorp
• F. Hoffmann-La Roche
• Guardant Health
• Sysmex Corporation
• NeoGenomics Laboratories
• Adaptive Biotechnologies Corporation
• ArcherDX
• Asuragen
• Arup Laboratories

MRD Testing Trends and Forecast

The future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $4.4 billion by 2030 with a CAGR of 12.8% from 2024 to 2030. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.

A more than 150-page report is developed to help in your business decisions.

MRD Testing by Segment

The study includes a forecast for the global MRD testing by technology, application, end use industry, and region.

MRD Testing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Flow Cytometry
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing (NGS)
• Others

MRD Testing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Hematological Malignancies
• Leukemia
• Lymphoma
• Solid Tumors
• Others

MRD Testing Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals and Specialty Clinics
• Diagnostic Laboratories
• Academic & Research Institutes
• Others

MRD Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of MRD Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies MRD testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the MRD testing companies profiled in this report include-

• Labcorp
• F. Hoffmann-La Roche
• Guardant Health
• Sysmex Corporation
• Neogenomics Laboratories
• Adaptive Biotechnologies Corporation
• Archerdx
• Asuragen
• Arup Laboratories

MRD Testing Market Insights

Lucintel forecasts that Polymerase Chain Reaction (PCR) is expected to witness highest growth over the forecast period.

Within this market, hospitals and specialty clinics will remain the largest segment.

APAC is expected to witness highest growth over the forecast period.

Features of the Global MRD Testing Market

Market Size Estimates: MRD testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: MRD testing market size by various segments, such as by application, end use industry, and region. in terms of value ($B).

Regional Analysis: MRD testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, applications, end use industries, and region.s for the MRD testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the MRD testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the MRD testing market size?

Answer: The global MRD testing market is expected to reach an estimated $4.4 billion by 2030.

Q.2. What is the growth forecast for MRD testing market?

Answer: The global MRD testing market is expected to grow with a CAGR of 12.8% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the MRD testing market?

Answer: The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.

Q.4. What are the major segments for MRD testing market?

Answer: The future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets.

Q.5. Who are the key MRD testing market companies?

Answer: Some of the key MRD testing companies are as follows:

• Labcorp
• F. Hoffmann-La Roche
• Guardant Health
• Sysmex Corporation
• NeoGenomics Laboratories
• Adaptive Biotechnologies Corporation
• ArcherDX
• Asuragen
• Arup Laboratories

Q.6. Which MRD testing market segment will be the largest in future?

Answer: Lucintel forecasts that next-generation sequencing (NGS) is expected to witness highest growth over the forecast period.

Q.7. In MRD testing market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the MRD testing market by technology (flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others), application (hematological malignancies, leukemia, lymphoma, solid tumors, and others), end use industry (hospitals and specialty clinics, diagnostic laboratories, academic & research institutes, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global MRD Testing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global MRD Testing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global MRD Testing Market by Technology
  • 3.3.1: Flow Cytometry
  • 3.3.2: Polymerase Chain Reaction (PCR)
  • 3.3.3: Next-Generation Sequencing (NGS)
  • 3.3.4: Others
• 3.4: Global MRD Testing Market by Application
  • 3.4.1: Hematological Malignancies
  • 3.4.2: Leukemia
  • 3.4.3: Lymphoma
  • 3.4.4: Solid Tumors
  • 3.4.5: Others
• 3.5: Global MRD Testing Market by End Use Industry
  • 3.5.1: Hospitals and Specialty Clinics
  • 3.5.2: Diagnostic Laboratories
  • 3.5.3: Academic & Research Institutes
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global MRD Testing Market by Region
• 4.2: North American MRD Testing Market
  • 4.2.2: North American MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
• 4.3: European MRD Testing Market
  • 4.3.1: European MRD Testing Market by Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others
  • 4.3.2: European MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
• 4.4: APAC MRD Testing Market
  • 4.4.1: APAC MRD Testing Market by Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others
  • 4.4.2: APAC MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
• 4.5: ROW MRD Testing Market
  • 4.5.1: ROW MRD Testing Market by Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others
  • 4.5.2: ROW MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global MRD Testing Market by Technology
  • 6.1.2: Growth Opportunities for the Global MRD Testing Market by Application
  • 6.1.3: Growth Opportunities for the Global MRD Testing Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global MRD Testing Market by Region
• 6.2: Emerging Trends in the Global MRD Testing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global MRD Testing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global MRD Testing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Labcorp
• 7.2: F. Hoffmann-La Roche
• 7.3: Guardant Health
• 7.4: Sysmex Corporation
• 7.5: NeoGenomics Laboratories
• 7.6: Adaptive Biotechnologies Corporation
• 7.7: ArcherDX
• 7.8: Asuragen
• 7.9: Arup Laboratories